Series B funding round for Oyster Point Pharmaceuticals raising $93M in February 2019
Series B funding round for Oyster Point Pharmaceuticals raising $93M in February 2019
| Investor | Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$115M
Top Valuation
-
Oyster Point Pharmaceuticals raised $93M in a Series B round.
The round was announced on 02/01/19.
The round was led by William Link, Benjamin Tsai.